Niraparib efficacy in patients with unresectable mesothelioma: a randomised phase II trial of niraparib versus active symptom control in patients with previously treated mesothelioma: NERO (TRIALS IN PROGRESS). (April 2023)

• Record Type: Journal Article
• Authors: Fennell, Dean; Griffiths, Daniel; Eminton, Zina; Morgan-Fox, Abigail; Hill, Kayleigh; Nearchou, Theodora; Johnson, Lucy; Harding, Stephanie; Poile, Charlotte; Bzura, Aleksandra; Spicer, Jake; Nye, Mavis; Cave, Judith; Danson, Sarah; Toy, Elizabeth; Jain, Pooja; Steele, Nicola; Shaw, Paul; Taylor, Paul; Szlosarek, Peter; Papadatos-Pastos, Dionysis; Lind, Michael; Dulloo, Sean; Saman, Harman; Bajaj, Amrita; Luo, Jin-Li; Darlison, Liz; Griffiths, Gareth
• Is Part Of: Lung cancer. Volume 178(2023)Supplement 1
• Page Start: S85
• Page End: S86
• Publication Date: 2023-04
• Subjects: Lungs -- Cancer -- Periodicals; Lung Neoplasms -- Abstracts; Lung Neoplasms -- Periodicals; Poumons -- Cancer -- Périodiques; Lungs -- Cancer; Periodicals; Electronic journals; Electronic journals; 616.99424
• DOI: 10.1016/S0169-5002(23)00620-7
• Languages: English
• ISSNs: 0169-5002